Feline Diabetes mellitus: Clinical use of long-acting glargine and detemir

Bloom, Carly Anne and Rand, Jacquie (2014) Feline Diabetes mellitus: Clinical use of long-acting glargine and detemir. Journal of Feline Medicine and Surgery, 16 3: 205-215. doi:10.1177/1098612X14523187


Author Bloom, Carly Anne
Rand, Jacquie
Title Feline Diabetes mellitus: Clinical use of long-acting glargine and detemir
Journal name Journal of Feline Medicine and Surgery   Check publisher's open access policy
ISSN 1098-612X
1532-2750
Publication date 2014-01-01
Year available 2014
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1177/1098612X14523187
Open Access Status DOI
Volume 16
Issue 3
Start page 205
End page 215
Total pages 11
Place of publication London, United Kingdom
Publisher Sage Publications Ltd.
Language eng
Subject 3404 Small Animals
Abstract Practical relevance: Diabetes mellitus is a common endocrine disorder in feline practice, affecting approximately 1 in 200 cats. The majority of diabetic cats have type 2 diabetes mellitus, which results from a combination of peripheral insulin resistance and a progressive reduction in insulin production. Clinical challenges: While usually easy to diagnose, management of diabetes mellitus presents a number of challenges for practitioners and clients alike. Practitioners must decide on diet, insulin type and dose, monitoring method and intensity, and concomitant therapy, which will vary based on individual patient and client needs, and geographic location. Practitioners may also encounter patients with diabetic ketoacidosis or other diabetic complications, and patients with multiple concurrent diseases. Clients may be challenged by the substantial time and financial commitment involved in owning a diabetic cat. Audience: Understanding the pathophysiology, optimal treatment protocols and current goals of diabetes management will benefit practitioners managing diabetic cats. This article reviews the most current management plans for feline diabetics. It places particular emphasis on best practice for achieving diabetic remission, which is an attainable goal in the majority of newly diagnosed diabetic cats. Evidence base: The information in this article is drawn from the recent human and veterinary literature, including prospective and retrospective studies. The body of prospective clinical data on the use of newer, long-acting insulins (glargine and especially detemir) in cats is limited, but growing.
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Official 2015 Collection
School of Veterinary Science Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Tue, 11 Mar 2014, 10:29:22 EST by System User on behalf of School of Veterinary Science